CN Patent

CN114555044A — 酒精性肝炎的治疗

Assigned to Durect Corp · Expires 2022-05-27 · 4y expired

What this patent protects

提供了治疗酒精性肝炎(AH)的方法。例如，所述方法可以包括施用5‑胆甾烯‑3,25‑二醇,3‑硫酸酯(25HC3S)或其盐。

USPTO Abstract

提供了治疗酒精性肝炎(AH)的方法。例如，所述方法可以包括施用5‑胆甾烯‑3,25‑二醇,3‑硫酸酯(25HC3S)或其盐。

Drugs covered by this patent

Patent Metadata

Patent number
CN114555044A
Jurisdiction
CN
Classification
—
Expires
2022-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Durect Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.